![Didier Launay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Didier Launay
Entité | Type d'entité | Industrie | |
---|---|---|---|
Remora Capital SA
![]() Remora Capital SA Investment ManagersFinance Remora Capital SA (Remora Capital) is a venture capital firm founded by Dr. Jean-Marc Le Doussal in 2009. The firm is headquartered in Switzerland.
4
| Subsidiary | Investment Managers | 4 |
Remora Partners SA
![]() Remora Partners SA Financial ConglomeratesFinance Remora Partners SA operates as an investment advisor. The private company is based in Lausanne, CH. and has subsidiaries in Switzerland and United States.
2
| Private Company | Financial Conglomerates | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Didier Launay via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Cytune Pharma SAS
![]() Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
DMS Biotechnology SRL
![]() DMS Biotechnology SRL BiotechnologyHealth Technology DMS Biotechnology Sprl develops biotechnology products. The private company is based in Mont-Saint-Guibert, Belgium. | Biotechnology | Corporate Officer/Principal | |
Vrije Universiteit Brussel | College/University | Doctorate Degree | |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Corporate Officer/Principal | |
Institute Gustave Rousse | Corporate Officer/Principal | ||
Hôpital Européen Georges-pompidou | Corporate Officer/Principal | ||
OGD2 Pharma SAS
![]() OGD2 Pharma SAS BiotechnologyHealth Technology OGD2 Pharma SAS develops and commercializes anti-GD2 cancer immunotherapies that target O-acetylated-GD2. The firm continues exploring the potential of therapies targeting the OAcGD2 antigen in various cancers. The company is headquartered in Nantes, France. | Biotechnology | President | |
Telix Pharmaceuticals SAS
![]() Telix Pharmaceuticals SAS BiotechnologyHealth Technology Telix Pharmaceuticals SAS engages in the pharmaceutical industry. It provides research in biotechnology. The company was founded on July 25, 2008 and is headquartered in Nantes, France. | Biotechnology | Chairman | |
Medevice Accelerator SAS
![]() Medevice Accelerator SAS Investment ManagersFinance Medevice Accelerator SAS (Medevice Accelerator) is an independent venture capital firm founded in 2011 by Cécile Réal. The firm is located in Chavanod (Alpes), France. | Investment Managers | Private Equity Investor | |
Patrick Choay SA
![]() Patrick Choay SA Real Estate DevelopmentFinance Patrick Choay SA operates as a holding company. The company is headquartered in Castelfranco Paris, France. | Real Estate Development | Chief Executive Officer |
Statistiques
Internationale
France | 10 |
Belgique | 4 |
Sectorielle
Health Technology | 7 |
Finance | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Opérationnelle
Corporate Officer/Principal | 7 |
Private Equity Investor | 3 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Didier Launay
- Connexions Sociétés